Literature DB >> 26696619

Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation.

Eric Tseng1, Mark A Crowther1, Christopher M Hillis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26696619      PMCID： PMC4786390          DOI： 10.1503/cmaj.150867

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  The Canadian Choosing Wisely campaign: the Canadian Hematology Society's top five tests and treatments.

Authors:  Christopher M Hillis; Aaron D Schimmer; Stephen Couban; Mark A Crowther
Journal:  Ann Hematol       Date:  2015-02-01       Impact factor: 3.673

3.  Pacemaker or defibrillator surgery without interruption of anticoagulation.

Authors:  David H Birnie; Jeff S Healey; George A Wells; Atul Verma; Anthony S Tang; Andrew D Krahn; Christopher S Simpson; Felix Ayala-Paredes; Benoit Coutu; Tiago L L Leiria; Vidal Essebag
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

4.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

Review 5.  How I treat anticoagulated patients undergoing an elective procedure or surgery.

Authors:  Alex C Spyropoulos; James D Douketis
Journal:  Blood       Date:  2012-08-28       Impact factor: 22.113

6.  Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.

Authors:  James D Douketis; Alex C Spyropoulos; Scott Kaatz; Richard C Becker; Joseph A Caprini; Andrew S Dunn; David A Garcia; Alan Jacobson; Amir K Jaffer; David F Kong; Sam Schulman; Alexander G G Turpie; Vic Hasselblad; Thomas L Ortel
Journal:  N Engl J Med       Date:  2015-06-22       Impact factor: 91.245

7.  Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.

Authors:  James D Douketis; Jeff S Healey; Martina Brueckmann; John W Eikelboom; Michael D Ezekowitz; Mandy Fraessdorf; Herbert Noack; Jonas Oldgren; Paul Reilly; Alex C Spyropoulos; Lars Wallentin; Stuart J Connolly
Journal:  Thromb Haemost       Date:  2014-12-04       Impact factor: 5.249

8.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

Review 9.  Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.

Authors:  Deborah Siegal; Jovana Yudin; Scott Kaatz; James D Douketis; Wendy Lim; Alex C Spyropoulos
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

10.  Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Authors:  Benjamin A Steinberg; Eric D Peterson; Sunghee Kim; Laine Thomas; Bernard J Gersh; Gregg C Fonarow; Peter R Kowey; Kenneth W Mahaffey; Matthew W Sherwood; Paul Chang; Jonathan P Piccini; Jack Ansell
Journal:  Circulation       Date:  2014-12-12       Impact factor: 29.690
  10 in total
  2 in total

Review 1.  Anticoagulation in CKD and ESRD.

Authors:  Kelvin Cheuk-Wai Leung; Jennifer Marie MacRae
Journal:  J Nephrol       Date:  2019-01-28       Impact factor: 3.902

2.  2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.

Authors:  Chern-En Chiang; Ken Okumura; Shu Zhang; Tze-Fan Chao; Chung-Wah Siu; Toon Wei Lim; Anil Saxena; Yoshihide Takahashi; Wee Siong Teo
Journal:  J Arrhythm       Date:  2017-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.